Back to Trades
Farag Kameel D.
Interim CFOCIK 0002093620
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 6
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 2
- Active
- 2025–2026
Across 6 filings between 2025–2026, Farag Kameel D., Interim CFO, has disclosed $194.6K in transactions — spread across 2 companies. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Jun 25 | AKTX Akari Therapeutics Plc | Farag Kameel D. | Interim CFO | Grant | $105.0K |
| Jan 9 | BIVI BIOVIE INC. | Farag Kameel D. | Director | Award | $75.3K |
| Dec 18 | AKTX Akari Therapeutics Plc | Farag Kameel D. | Interim CFO | Other | $9.6K |
| Oct 28 | BIVI BIOVIE INC. | Farag Kameel D. | Director | Other | $0 |
| Oct 24 | AKTX Akari Therapeutics Plc | Farag Kameel D. | Interim CFO | Grant | $4.6K |
| Oct 24 | AKTX Akari Therapeutics Plc | Farag Kameel D. | Interim CFO | Other | $0 |
6 filings